The value of time in therapeutic range in the prediction of outcomes at a populational level in patients treated with vitamin K antagonists

被引：1
作者：
Caldeira, Daniel [1 ,2 ]
机构：
[1] Univ Lisbon, Fac Med, Lab Farmacol Clin & Terapeut, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal
[2] Inst Med Mol, Clin Pharmacol Unit, Lisbon, Portugal
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2018年 / 34卷 / 03期
关键词：
ATRIAL-FIBRILLATION; ORAL ANTICOAGULANT; ADVERSE EVENTS; WARFARIN; METAANALYSIS; INTENSITY; QUALITY; RATIO;
D O I：
10.1080/03007995.2017.1411794
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：499 / 500
页数：2
相关论文
共 15 条
[11]   Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT2R2 score [J].
Proietti, Marco ;
Lip, Gregory Y. H. .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2015, 1 (03) :150-152
[12]  
ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236
[13]   Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation? The ATRIA Study [J].
Singer, Daniel E. ;
Chang, Yuchiao ;
Fang, Margaret C. ;
Borowsky, Leila H. ;
Pomernacki, Niela K. ;
Udaltsova, Natalia ;
Go, Alan S. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (04) :297-U30
[14]   Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation A Systematic Review [J].
Wan, Yi ;
Heneghan, Carl ;
Perera, Rafael ;
Roberts, Nia ;
Hollowell, Jennifer ;
Glasziou, Paul ;
Bankhead, Clare ;
Xu, Yongyong .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2008, 1 (02) :84-91
[15]   Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control - Results from SPORTIF III and IV [J].
White, Harvey D. ;
Gruber, Michael ;
Feyzi, Jan ;
Kaatz, Scott ;
Tse, Hung-Fat ;
Husted, Steen ;
Albers, Gregory W. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (03) :239-245
12